Published in J Gene Med on January 01, 2004
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res (2004) 3.03
Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev (2009) 2.28
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo. ACS Nano (2013) 1.11
Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells. Mol Pharm (2010) 0.95
Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated Poly(amido amine)s. Pharm Res (2011) 0.92
Understanding nonviral nucleic acid delivery with quantum dot-FRET nanosensors. Nanomedicine (Lond) (2012) 0.88
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery. Adv Funct Mater (2013) 0.87
PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses. Mol Ther (2012) 0.84
Enhanced Performance of Plasmid DNA Polyplexes Stabilized by a Combination of Core Hydrophobicity and Surface PEGylation. J Mater Chem B Mater Biol Med (2014) 0.81
Self-assembled lipid nanomedicines for siRNA tumor targeting. J Biomed Nanotechnol (2009) 0.80
Biophysical characterization of copolymer-protected gene vectors. Biomacromolecules (2010) 0.78
Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy. J Control Release (2014) 0.78
Characterization of complexation of poly (N-isopropylacrylamide-co-2-(dimethylamino) ethyl methacrylate) thermoresponsive cationic nanogels with salmon sperm DNA. Int J Nanomedicine (2009) 0.77
Reducible, dibromomaleimide-linked polymers for gene delivery. Biomater Sci (2014) 0.76
Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo. J Control Release (2017) 0.75
Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment. Pharm Res (2017) 0.75
Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res (2000) 2.17
Cationic polymer based gene delivery systems. Pharm Res (2000) 1.98
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets (2009) 1.70
Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev (2001) 1.62
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther (2001) 1.55
Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release (2007) 1.45
An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. J Control Release (2011) 1.43
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res (2007) 1.39
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum (2000) 1.32
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther (2000) 1.32
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis (1993) 1.30
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23
Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery. Bioconjug Chem (1999) 1.22
Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta (1993) 1.14
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res (2003) 1.11
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis (2004) 1.09
Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior. J Control Release (2001) 1.09
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther (2000) 1.08
Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem (2002) 1.07
Thermosensitive polymers as carriers for DNA delivery. J Control Release (1999) 1.04
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother (2001) 1.03
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res (1987) 1.01
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
Controlled release of a model protein from enzymatically degrading dextran microspheres. J Control Release (1999) 1.00
In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. Biomaterials (2001) 0.99
Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med (1995) 0.99
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med (1999) 0.99
In vivo applications of PEG liposomes: unexpected observations. Crit Rev Ther Drug Carrier Syst (2001) 0.98
Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm (2006) 0.98
Photopolymerized thermosensitive hydrogels for tailorable diffusion-controlled protein delivery. J Control Release (2009) 0.98
An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Gene Med (2005) 0.98
Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres. Biomaterials (2002) 0.98
Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach. Angiogenesis (2011) 0.98
Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application. Int J Pharm (2006) 0.97
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Optimization of poly(amido amine)s as vectors for siRNA delivery. J Control Release (2010) 0.97
Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim Biophys Acta (1999) 0.96
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med (2000) 0.96
Micelles based on HPMA copolymers. Adv Drug Deliv Rev (2009) 0.96
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. Int J Pharm (1999) 0.95
Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost (2007) 0.95
Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharm Res (2001) 0.94
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta (1999) 0.94
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta (2001) 0.93
The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials (2004) 0.93
Degradation kinetics of methacrylated dextrans in aqueous solution. J Pharm Sci (1997) 0.92
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta (1999) 0.92
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Effect of molecular weight and glass transition on relaxation and release behaviour of poly(DL-lactic acid) tablets. J Control Release (2001) 0.92
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release (2003) 0.91
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med (1996) 0.91
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate. Biomaterials (2001) 0.90
Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J Control Release (2003) 0.89
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta (1985) 0.88
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol). Pharm Res (1997) 0.88
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Inflamm Res (2001) 0.88
Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomed Microdevices (2009) 0.88
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev (2010) 0.88
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. Int J Pharm (1999) 0.87
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J Control Release (1999) 0.86
Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors. Anal Biochem (2001) 0.86
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes. Biochim Biophys Acta (1998) 0.86
Liposomes in treatment of infectious diseases. Pharm Weekbl Sci (1987) 0.86
Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J Control Release (2009) 0.85
Microspheres with ultrahigh holmium content for radioablation of malignancies. Pharm Res (2009) 0.85
Peptide-targeted PEG-liposomes in anti-angiogenic therapy. Int J Pharm (2003) 0.85
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm Res (2000) 0.85
Microscopic localization of PEG-liposomes in a rat model of focal infection. J Control Release (2001) 0.85
Removal of chloroform from biodegradable therapeutic microspheres by radiolysis. Int J Pharm (2006) 0.85
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther (2001) 0.84
Radiolabeled liposomes for scintigraphic imaging. Prog Lipid Res (2000) 0.84
The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm Res (1998) 0.84
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. Br J Cancer (1996) 0.84
In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Cancer Res (1992) 0.83
Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. Int J Pharm (2011) 0.83
Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization. J Drug Target (2000) 0.83
Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur J Pharm Sci (2007) 0.83
In vivo biocompatibility of dextran-based hydrogels. J Biomed Mater Res (2000) 0.83